\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\	on\\ the\\ scalp\\ there\\ were\\ numerous\\ 1\\-2\\ cm\\ subcutaneous\\ erythematous\\ nodules\\ with\\ overlying\\ partial\\ alopecia\\.\\ \ \(0\)\
\-\ laboratory\\:\\	hct\\ \\=\\ 32\\,\\ wbc\\ \\=\\ 7\\.2\\,\\ neuts\\ 9\\,\\ blasts\\ 10\\,\\ lymphs\\ 65\\,\\ plts\\ 50k\ \(0\)\
\-\ histopathology\\:\\ sections\\ demonstrated\\ a\\ dense\\,\\ diffuse\\ infiltrate\\ of\\ atypical\\ monomorphic\\ lymphoid\\ cells\\ that\\ replaced\\ much\\ of\\ the\\ dermis\\ and\\ subcutaneous\\ tissue\\.\\ immunophenotyping\\ of\\ cells\\ from\\ paraffin\\ block\\ revealed\\ a\\ t\\-cell\\ population\\.\\ flow\\ cytometry\\ demonstrated\\ this\\ population\\ to\\ be\\ cd2\\+\\,\\ cd3\\+\\,\\ cd4\\+\\,\\ cd8\\+\\,\\ c5\\+\\,\\ and\\ cd7\\+\\ as\\ well\\ as\\ cd10\\+\\.\\ these\\ findings\\ were\\ consistent\\ with\\ the\\ diagnosis\\ of\\ t\\-cell\\ lymphoblastic\\ leukemia\\,\\ group\\ 2\\.\ \(0\)\
\-\ the\\ patient\\ was\\ admitted\\ to\\ the\\ oncology\\ service\\ for\\ a\\ chemotherapy\\ regimen\\ to\\ include\\ cyclophosphamide\\,danorubicin\\,vincristine\\,prednisone\\,\\ l\\-asparaginase\\,\\ cytarabine\\,\\ 6\\-mp\\,\\ and\\ mtx\\.\\ the\\ scalp\\ nodules\\ resolved\\ after\\ the\\ second\\ course\\ of\\ chemotherapy\\.\\ he\\ is\\ currently\\ in\\ clinical\\ remission\\ undergoing\\ late\\ intensification\\.\ \(0\)\
\-\ all\\ t\\-cell\\ subtype\\ leukemia\\ cutis\\ \\(1997\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ case\\#14\\)\\ submitted\\ by\\:\\ richard\\ laws\\,\\ cpt\\,\\ mc\\,\\ usa\ \(0\)\
\-\ presented\\ with\\ a\\ five\\ month\\ history\\ of\\ an\\ increasing\\ number\\ of\\ asymptomatic\\ scalp\\ nodules\\.\\ these\\ were\\ originally\\ diagnosed\\ as\\ bug\\ bites\\ by\\ his\\ primary\\ care\\ physician\\.\\ two\\ weeks\\ before\\ presenting\\ to\\ the\\ dermatology\\ clinic\\,\\ the\\ patient\\ had\\ a\\ cbc\\ as\\ part\\ of\\ gulf\\ war\\ veteran\\ screening\\ which\\ revealed\\ increased\\ lymphocytes\\ and\\ the\\ presence\\ of\\ blast\\ cells\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ scalp\\:\\ 0\\.21734860845618473\ \(0\)\
\-\ nodules\\:\\ 0\\.1701331488884659\ \(0\)\
\-\ cells\\:\\ 0\\.1649782031115438\ \(0\)\
\-\ the\\:\\ 0\\.14241718607386042\ \(0\)\
\-\ dermatology\\:\\ 0\\.13967511157547086\ \(0\)\
\-\ subcutaneous\\:\\ 0\\.13597350136490186\ \(0\)\
\-\ population\\:\\ 0\\.13505225434644622\ \(0\)\
\-\ leukemia\\:\\ 0\\.1303894713377552\ \(0\)\
\-\ of\\:\\ 0\\.12570835413999779\ \(0\)\
\-\ as\\:\\ 0\\.1146940317494773\ \(0\)\
\-\ neuts\\:\\ 0\\.11414271960241175\ \(0\)\
\-\ 50k\\:\\ 0\\.11414271960241175\ \(0\)\
\-\ monomorphic\\:\\ 0\\.11414271960241175\ \(0\)\
\-\ immunophenotyping\\:\\ 0\\.11414271960241175\ \(0\)\
\-\ danorubicin\\:\\ 0\\.11414271960241175\ \(0\)\
\-\ cytarabine\\:\\ 0\\.11414271960241175\ \(0\)\
\-\ intensification\\:\\ 0\\.11414271960241175\ \(0\)\
\-\ laws\\:\\ 0\\.11414271960241175\ \(0\)\
\-\ veteran\\:\\ 0\\.11414271960241175\ \(0\)\
\-\ were\\:\\ 0\\.11037385421610567\ \(0\)\
\-\ blasts\\:\\ 0\\.10906946221876428\ \(0\)\
\-\ paraffin\\:\\ 0\\.10906946221876428\ \(0\)\
\-\ mtx\\:\\ 0\\.10906946221876428\ \(0\)\
\-\ bug\\:\\ 0\\.10906946221876428\ \(0\)\
\-\ gulf\\:\\ 0\\.10906946221876428\ \(0\)\
\-\ cutis\\:\\ 0\\.10546992882113425\ \(0\)\
\-\ bites\\:\\ 0\\.10546992882113425\ \(0\)\
\-\ richard\\:\\ 0\\.10267791380756092\ \(0\)\
\-\ war\\:\\ 0\\.10267791380756092\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.10136066188589628\ \(0\)\
\-\ alopecia\\:\\ 0\\.09846790849589405\ \(0\)\
\-\ lymphs\\:\\ 0\\.09846790849589405\ \(0\)\
\-\ lymphoblastic\\:\\ 0\\.09846790849589405\ \(0\)\
\-\ cpt\\:\\ 0\\.09846790849589405\ \(0\)\
\-\ cytometry\\:\\ 0\\.09679713803985676\ \(0\)\
\-\ plts\\:\\ 0\\.0953234140538393\ \(0\)\
\-\ revealed\\:\\ 0\\.09359922570494453\ \(0\)\
\-\ cyclophosphamide\\:\\ 0\\.08893186564263594\ \(0\)\
\-\ demonstrated\\:\\ 0\\.0877291995991553\ \(0\)\
\-\ lymphoid\\:\\ 0\\.08736580033527899\ \(0\)\
\-\ remission\\:\\ 0\\.08665062327256182\ \(0\)\
\-\ usa\\:\\ 0\\.08597412380556069\ \(0\)\
\-\ blast\\:\\ 0\\.08533233224500593\ \(0\)\
\-\ vincristine\\:\\ 0\\.08413979295183432\ \(0\)\
\-\ subtype\\:\\ 0\\.08413979295183432\ \(0\)\
\-\ sections\\:\\ 0\\.08305108987493179\ \(0\)\
\-\ replaced\\:\\ 0\\.08068325759352557\ \(0\)\
\-\ dermis\\:\\ 0\\.08068325759352557\ \(0\)\
\-\ these\\:\\ 0\\.08060988278785529\ \(0\)\
\-\ lymphocytes\\:\\ 0\\.08025907486135844\ \(0\)\
\-\ block\\:\\ 0\\.07984880229432698\ \(0\)\
\-\ regimen\\:\\ 0\\.07906653556818684\ \(0\)\
\-\ oncology\\:\\ 0\\.07635058274782278\ \(0\)\
\-\ infiltrate\\:\\ 0\\.07575465144233791\ \(0\)\
\-\ submitted\\:\\ 0\\.07546700217055682\ \(0\)\
\-\ prednisone\\:\\ 0\\.07518581747771097\ \(0\)\
\-\ mc\\:\\ 0\\.0749108131713829\ \(0\)\
\-\ service\\:\\ 0\\.07386752645015508\ \(0\)\
\-\ originally\\:\\ 0\\.07267498715698348\ \(0\)\
\-\ erythematous\\:\\ 0\\.07244953615206157\ \(0\)\
\-\ histopathology\\:\\ 0\\.07201046681224807\ \(0\)\
\-\ seminar\\:\\ 0\\.07179657797563774\ \(0\)\
\-\ to\\:\\ 0\\.0713735363951387\ \(0\)\
\-\ uniformed\\:\\ 0\\.07117601151304949\ \(0\)\
\-\ 1997\\:\\ 0\\.07058477433339376\ \(0\)\
\-\ services\\:\\ 0\\.07002021877272399\ \(0\)\
\-\ group\\:\\ 0\\.06783131772398937\ \(0\)\
\-\ hct\\:\\ 0\\.06767779196654528\ \(0\)\
\-\ late\\:\\ 0\\.0673762787684141\ \(0\)\
\-\ number\\:\\ 0\\.06570550831237681\ \(0\)\
\-\ undergoing\\:\\ 0\\.06482489025252752\ \(0\)\
\-\ five\\:\\ 0\\.06446566388818524\ \(0\)\
\-\ resolved\\:\\ 0\\.06411646376577707\ \(0\)\
\-\ part\\:\\ 0\\.06377674537078408\ \(0\)\
\-\ dense\\:\\ 0\\.06291349329880346\ \(0\)\
\-\ physician\\:\\ 0\\.0626045345828978\ \(0\)\
\-\ much\\:\\ 0\\.06181610421513016\ \(0\)\
\-\ 32\\:\\ 0\\.06116476500645793\ \(0\)\
\-\ 65\\:\\ 0\\.061074423875715086\ \(0\)\
\-\ overlying\\:\\ 0\\.06080724947718372\ \(0\)\
\-\ by\\:\\ 0\\.06061916236227419\ \(0\)\
\-\ numerous\\:\\ 0\\.06028942969621248\ \(0\)\
\-\ clinic\\:\\ 0\\.060121478285230116\ \(0\)\
\-\ cbc\\:\\ 0\\.0595507907997864\ \(0\)\
\-\ and\\:\\ 0\\.0589943334226409\ \(0\)\
\-\ atypical\\:\\ 0\\.05855541297787316\ \(0\)\
\-\ admitted\\:\\ 0\\.05848202747571075\ \(0\)\
\-\ screening\\:\\ 0\\.05798003840031589\ \(0\)\
\-\ before\\:\\ 0\\.057701978240449404\ \(0\)\
\-\ increasing\\:\\ 0\\.056212986171694436\ \(0\)\
\-\ presenting\\:\\ 0\\.05591147297356327\ \(0\)\
\-\ partial\\:\\ 0\\.0549927343705146\ \(0\)\
\-\ currently\\:\\ 0\\.054827736037726456\ \(0\)\
\-\ second\\:\\ 0\\.05343318413346929\ \(0\)\
\-\ 14\\:\\ 0\\.05328740937097228\ \(0\)\
\-\ course\\:\\ 0\\.052720722684924635\ \(0\)\
\-\ laboratory\\:\\ 0\\.05182979896380881\ \(0\)\
\-\ diagnosed\\:\\ 0\\.0517014676618964\ \(0\)\
\-\ presence\\:\\ 0\\.05128296068045071\ \(0\)\
\-\ care\\:\\ 0\\.05099811798662842\ \(0\)\
\-\ wbc\\:\\ 0\\.05044717775726542\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.048590118119358414\ \(0\)\
\-\ flow\\:\\ 0\\.04754019539041694\ \(0\)\
\-\ patient\\:\\ 0\\.046428821514122344\ \(0\)\
\-\ clinical\\:\\ 0\\.04523354754511531\ \(0\)\
\-\ diffuse\\:\\ 0\\.04476039335219179\ \(0\)\
\-\ primary\\:\\ 0\\.043887369946445674\ \(0\)\
\-\ month\\:\\ 0\\.043417688283229894\ \(0\)\
\-\ his\\:\\ 0\\.04328666936617434\ \(0\)\
\-\ weeks\\:\\ 0\\.04277589672267513\ \(0\)\
\-\ all\\:\\ 0\\.04248729959344495\ \(0\)\
\-\ include\\:\\ 0\\.04246693800676946\ \(0\)\
\-\ two\\:\\ 0\\.04238582140337197\ \(0\)\
\-\ he\\:\\ 0\\.04226512407917592\ \(0\)\
\-\ with\\:\\ 0\\.04192782161721392\ \(0\)\
\-\ 10\\:\\ 0\\.04173594703100459\ \(0\)\
\-\ presented\\:\\ 0\\.041621330728000006\ \(0\)\
\-\ cm\\:\\ 0\\.04099095366626103\ \(0\)\
\-\ physical\\:\\ 0\\.038700673959390385\ \(0\)\
\-\ consistent\\:\\ 0\\.038700673959390385\ \(0\)\
\-\ increased\\:\\ 0\\.03859571786673133\ \(0\)\
\-\ tissue\\:\\ 0\\.03744124263844625\ \(0\)\
\-\ diagnosis\\:\\ 0\\.03699982610365131\ \(0\)\
\-\ exam\\:\\ 0\\.03592975622788536\ \(0\)\
\-\ case\\:\\ 0\\.035857570303141136\ \(0\)\
\-\ had\\:\\ 0\\.035561199454113436\ \(0\)\
\-\ findings\\:\\ 0\\.035225979796709384\ \(0\)\
\-\ after\\:\\ 0\\.03462474457971854\ \(0\)\
\-\ well\\:\\ 0\\.03455968970742623\ \(0\)\
\-\ which\\:\\ 0\\.032454512133845696\ \(0\)\
\-\ that\\:\\ 0\\.03097368154325116\ \(0\)\
\-\ be\\:\\ 0\\.028953617851301912\ \(0\)\
\-\ there\\:\\ 0\\.028399531766831933\ \(0\)\
\-\ from\\:\\ 0\\.028346765458789284\ \(0\)\
\-\ an\\:\\ 0\\.027293215183940265\ \(0\)\
\-\ history\\:\\ 0\\.0272690370271398\ \(0\)\
\-\ was\\:\\ 0\\.02487457950945804\ \(0\)\
\-\ this\\:\\ 0\\.024525425138729615\ \(0\)\
\-\ for\\:\\ 0\\.021632941086723312\ \(0\)\
\-\ on\\:\\ 0\\.02155620246991064\ \(0\)\
\-\ is\\:\\ 0\\.019546281433212367\ \(0\)\
\-\ in\\:\\ 0\\.017755558999205372\ \(0\)\
